11.05.2021 • NewsCroda

Croda Reviews PTIC businesses

Croda International has announced it is undertaking a strategic review of its Performance Technologies and Industrial Chemicals (PTIC) businesses. The primary aim, said the UK specialty chemicals company, will be to establish what type of ownership structure best serves the businesses going forward and create a stronger platform for its future growth.

The review expected to conclude by the end of 2021 is consistent with Croda’s prioritization of investments in faster-growth life science and consumer markets, which now represent over 80% of the group’s profitability, the company said. Its focus will be on the businesses and activities within PTIC that do not directly support the consumer care and life sciences sectors and will consider whether their full potential can be achieved under Croda, as a standalone business, or through a full or partial divestment.

PTIC’s manufacturing assets include facilities in the UK, The Netherlands, and China. The business focuses on fast-growth markets in the circular plastic economy, electric vehicles and other renewable technologies, supporting the division’s leading market positions in automotive, polymer and food packaging applications.

Author: Elaine Burridge, Freelance Journalist

Croda is undertaking a strategic review of its Performance Technologies and...
Croda is undertaking a strategic review of its Performance Technologies and Industrial Chemicals businesses. The review, expected to conclude by end 2021, will consider whether the businesses will do best under Croda, as a standalone company, or via a full or partial divestment. (c) Croda

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.